Description: This session from the 1993 Valuation Actuary Symposium looks at an overview of developments in 1993 including a regulator's viewpoint of various valuation actuary issues, an update on the valuation actuary and health insurance, current developments in reinsurance that should be considered in the valuation process and a sample actuarial opinion and memorandum.

Description: 1996 Valuation Actuary Symposium. Questions asked and answered included: 1. What do regulators expect or want as far as asset adequacy analysis for shorter-term liabilities such as IBNR? 2. What responsibility does the appointed actuary have in verifying reserves for reinsured business? 3. If the assets for the market value adjusted annuity are held in a separate account and valued at market, what rates should be used to present value the projected guaranteed benefits? 4. May a company perform the cash-flow testing based on the low level of reserves held in the domiciliary state rather than the higher reserve actually held in the state with the special state in filing? 5. Have there been any situations where an opining valuation actuary has been held personally responsible?

Description: 1992 SOA Annual Meeting, Washington, D.C. This session on cash-flow testing for product actuaries covered the following topics: 1. Guidance notes designed to help in writing up reports on cash-flow testing. 2. Investment strategies in product design. 3. Surplus requirements.